Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Litvan

Showing results (261-270 of 331) with videos related to

Pageof 34
Sort By:
Neurology|February 13, 2019
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseasesAlberto J Espay, Joaquin A Vizcarra, Luca Marsili, et al.
JAMA Neurology|April 3, 2023
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal SyndromeLawren VandeVrede, Renaud La Joie, Elisabeth H Thijssen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2023
A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's DiseaseFrancisco Cardoso, Christopher G Goetz, Tiago A Mestre, et al.
Neurology|June 8, 2021
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body DisordersAndrea Pilotto, Alberto Romagnolo, Andrea Scalvini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 28, 2023
Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degenerationBreton M Asken, Peter A Ljubenkov, Adam M Staffaroni, et al.
The Lancet. Neurology|May 31, 2014
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trialAdam L Boxer, Anthony E Lang, Murray Grossman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2021
The contribution of behavioral features to caregiver burden in FTLD spectrum disordersHannah E Silverman, Jeannie M Ake, Masood Manoochehri, et al.
Neurology|May 18, 2022
Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal DementiaGianina Toller, Yann Cobigo, Peter A Ljubenkov, et al.
Neurology|July 3, 2024
CSF Proteomics in Patients With Progressive Supranuclear PalsyAmy Wise, Jingyao Li, Mai Yamakawa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 2, 2023
Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementiaGianina Toller, Yann Cobigo, Patrick Callahan, et al.
Pageof 34

Showing results (261-270 of 331) with videos related to

Sort By:
Pageof 34
Neurology|February 13, 2019
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseasesAlberto J Espay, Joaquin A Vizcarra, Luca Marsili, et al.
JAMA Neurology|April 3, 2023
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal SyndromeLawren VandeVrede, Renaud La Joie, Elisabeth H Thijssen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2023
A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's DiseaseFrancisco Cardoso, Christopher G Goetz, Tiago A Mestre, et al.
Neurology|June 8, 2021
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body DisordersAndrea Pilotto, Alberto Romagnolo, Andrea Scalvini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 28, 2023
Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degenerationBreton M Asken, Peter A Ljubenkov, Adam M Staffaroni, et al.
The Lancet. Neurology|May 31, 2014
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trialAdam L Boxer, Anthony E Lang, Murray Grossman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2021
The contribution of behavioral features to caregiver burden in FTLD spectrum disordersHannah E Silverman, Jeannie M Ake, Masood Manoochehri, et al.
Neurology|May 18, 2022
Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal DementiaGianina Toller, Yann Cobigo, Peter A Ljubenkov, et al.
Neurology|July 3, 2024
CSF Proteomics in Patients With Progressive Supranuclear PalsyAmy Wise, Jingyao Li, Mai Yamakawa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 2, 2023
Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementiaGianina Toller, Yann Cobigo, Patrick Callahan, et al.
Pageof 34